<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Mol Med (Berl)</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Mol. Med</journal-id>
<journal-title-group>
<journal-title>Journal of Molecular Medicine (Berlin, Germany)</journal-title>
</journal-title-group>
<issn pub-type="ppub">0946-2716</issn>
<issn pub-type="epub">1432-1440</issn>
<publisher>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
<publisher-loc>Berlin/Heidelberg</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27858116</article-id>
<article-id pub-id-type="pmc">5225196</article-id>
<article-id pub-id-type="publisher-id">1486</article-id>
<article-id pub-id-type="doi">10.1007/s00109-016-1486-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Hae Ung</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McPherson</surname>
<given-names>Zachary E</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Bryan</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Korecka</surname>
<given-names>Agata</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pettersson</surname>
<given-names>Sven</given-names>
</name>
<address>
<phone>+65 91540498</phone>
<email>Sven.Pettersson@ki.se</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label>The LKC School of Medicine, Nanyang Technological University, Singapore, Singapore </aff>
<aff id="Aff2"><label>2</label>The School of Medicine and Public Health, University of Newcastle, Newcastle, Australia </aff>
<aff id="Aff3"><label>3</label>The School of Medicine, Imperial College, London, UK </aff>
<aff id="Aff4"><label>4</label>Department of Microbiology, Cell and Tumor Biology, Karolinska Institutet, Solna, Sweden </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<volume>95</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>39</lpage>
<history>
<date date-type="received">
<day>5</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>The microbiome located within a given host and its organs forms a holobiont, an intimate functional entity with evolutionarily designed interactions to support nutritional intake and reproduction. Thus, all organs in a holobiont respond to changes within the microbiome. The development and function of the central nervous system and its homeostatic mechanisms are no exception and are also subject to regulation by the gut microbiome. In order for the holobiont to function effectively, the microbiome and host must communicate. The aryl hydrocarbon receptor is an evolutionarily conserved receptor recognizing environmental compounds, including a number of ligands produced directly and indirectly by the microbiome. This review focuses on the microbiome-gut-brain axis in regard to the aryl hydrocarbon receptor signaling pathway and its impact on underlying mechanisms in neurodegeneration.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Host-microbiome interactions</kwd>
<kwd>Neurodevelopment</kwd>
<kwd>Neurodegeneration</kwd>
<kwd>Aryl hydrocarbon receptor</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001459</institution-id>
<institution>Ministry of Education - Singapore</institution>
</institution-wrap>
</funding-source>
<award-id>1T1-04/15</award-id>
<principal-award-recipient>
<name>
<surname>Pettersson</surname>
<given-names>Sven</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution>Lee Kong Chian</institution>
</funding-source>
<award-id>Start Up Grant</award-id>
<principal-award-recipient>
<name>
<surname>Pettersson</surname>
<given-names>Sven</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution>Singapore Centre On Environmental Life Sciences</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer-Verlag Berlin Heidelberg 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p>The alimentary tract contains trillions of microbes with overlapping biological and biochemical needs due to coevolutionary mechanisms, collectively termed the gut microbiome. Though researchers have shown that the gut microbiome impacts virtually all aspects of host function, the mechanisms and signaling pathways by which the gut microbiota communicates with its host are still unknown.</p>
<p>Bacteria and archaea, two of the predominant kingdoms within the microbiome, were the dominant forms of life on Earth for approximately three billion years prior to the evolution of the animal kingdom [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Current understanding increasingly considers the host and its microbiome as a working functional unit known as the holobiont. Environmental changes affect both the host and its microbiome. The last decade of genome-wide association studies has ignored the microbiome and, consequently, missed the response elicited within it. In the last 20 years, germ-free (GF) mice, mice that are raised without exposure to any microbes, have been used to address the holobiont concept using a systems biology approach [<xref ref-type="bibr" rid="CR3">3</xref>]. A prerequisite for a holobiont to function is the ability of the host and microbiome to communicate, to maintain homeostasis, and to act correspondingly when exposed to assaults. We postulate that many of the ligands and receptors identified and used for host-microbiome interactions are evolutionary. This review focuses on the well-described xenobiotic aryl hydrocarbon receptor (AHR) as one possible evolutionarily conserved signaling pathway that contributes to host-microbiome homeostasis within the holobiont.</p>
<sec id="Sec2">
<title>The aryl hydrocarbon receptor</title>
<p>The AHR is a cytoplasmic ligand-induced receptor originally discovered as a xenobiotic sensor mediating the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), also known as dioxin [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. The metabolism of xenobiotic compounds is initiated by activation of the AHR, which then translocates to the nucleus, where it acts as a transcription factor for specific target genes, such as cytochrome P450 1A1 and cytochrome P450 1B1 [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. However, invertebrates do not have a toxic response to dioxin, and none of the currently known invertebrate AHR orthologues, including spineless in <italic>Drosophila</italic>, have dioxin binding capacity, which suggests that the ancestral role of the AHR is not specifically toxin response [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Furthermore, physiological roles of the AHR in responses to endogenous ligands have been reported in cell cycle regulation, cell differentiation, and immune responses [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. A number of endogenous AHR ligands have been suggested through in silico research and biological testing, including tryptophan metabolites [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Recently, our group discovered that AHR expression is attenuated in GF mice [<xref ref-type="bibr" rid="CR20">20</xref>]. This finding suggests that the AHR acts as a mediator in communication between the host and gut microbiota.</p>
</sec>
<sec id="Sec3">
<title>Function of the aryl hydrocarbon receptor in host-environment interactions</title>
<p>Dioxin-activated AHR attenuates lipid metabolism via negative regulation of peroxisome proliferator-activated receptor (PPAR) [<xref ref-type="bibr" rid="CR21">21</xref>]. Dysregulation of lipid metabolism leading to hepatic steatosis and insulin resistance suggests that the AHR plays an important role in integrating exogenous and endogenous influences in lipid and energy metabolism [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Findings from AHR-deficient mice show that, like GF mice [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], they are protected from high fat diet-induced obesity, hepatic steatosis, and insulin resistance [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
<p>Recently, fibroblast growth factor 21 (FGF21) was reported to be a novel target gene of the AHR. FGF21 increases lipid oxidation and ketogenesis but decreases gluconeogenesis at the gene expression level [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. As an insulin sensitizer, FGF21 boosts the metabolic benefits such as improved blood glucose levels due to increased glucose uptake in adipocytes, reduced body weight due to increased energy expenditure, and improved blood lipid profiles due to hepatic sequestration of lipid droplets [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref>]. TCDD-induced AHR activation has been shown to increase FGF21 messenger RNA (mRNA) in both a dose- and time-dependent manner in mouse liver [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. In addition, drug-induced overexpression of human AHR in mice induces the activation of FGF21 which may then result in decreased insulin resistance [<xref ref-type="bibr" rid="CR32">32</xref>]. The opposite effects were observed with the downregulation of FGF21—insulin insensitivity, deranged lipid profile, and liver inflammation—and can be associated with the attenuation of hepatic lipid accumulation and increased transfer of fats out of the liver in hepatocyte-targeted AHR knockout (KO) [<xref ref-type="bibr" rid="CR22">22</xref>]<italic>.</italic>
</p>
<p>Recent work from our lab linked the mechanism of microbiota and host communication through an AHR-dependent mechanism. We demonstrated that the AHR is differentially expressed in GF mice. Similarly, our AHR-KO study showed that AHR regulates a set of metabolic genes in the liver, including CD36 (involved in fatty acid uptake) and Hmgcs2 (an enzyme involved in ketone body regulation) [<xref ref-type="bibr" rid="CR20">20</xref>]. Similar to fast-induced adipose factor-KO mice [<xref ref-type="bibr" rid="CR25">25</xref>], AHR-KO mice gain weight as expected but do not develop insulin resistance [<xref ref-type="bibr" rid="CR20">20</xref>], suggesting that AHR could be the upstream link between microbiota-mediated signals and the host [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
<p>
<italic>S</italic>everal reports have associated AHR function with the regulation of the immune system. TCDD treatment has shown that AHR has the capacity to mediate the differentiation and/or function of T cells, macrophages, and dendritic cells [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR37">37</xref>]. The activation of AHR by TCDD [<xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR40">40</xref>] and the ablation of AHR in KO animals [<xref ref-type="bibr" rid="CR41">41</xref>] have implicated this receptor in viral immunity. We also recently reported that ablating the AHR in CD11c<sup>+</sup> cells perturbs the development of the intestinal epithelium and intestinal immunity [<xref ref-type="bibr" rid="CR42">42</xref>]. Depending on the presence of specific ligands, AHR activation has also been shown to suppress or exacerbate responses in experimental autoimmune disease models. For example, TCDD and 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) can suppress experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS) [<xref ref-type="bibr" rid="CR35">35</xref>], whereas the activation of AHR by ligands such as 6-formylindolo[3,2-b]carbazole (FICZ) exacerbates the development of EAE [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. In addition, the affinity of AHR for ligands (TCDD, high affinity; FICZ, low affinity) influenced the amount of IL-17 and IL-22 protein secreted by Th17 cells [<xref ref-type="bibr" rid="CR44">44</xref>]. These findings indicate that various ligands for AHR may have different effects on host development.</p>
</sec>
<sec id="Sec4">
<title>Natural ligands for the aryl hydrocarbon receptor</title>
<p>Though most research on AHR has focused on man-made high affinity binding ligands and chemical pollutants, recent research has implicated important roles for an array of low affinity natural ligands produced, metabolized, or influenced by the gut microbiota. Natural ligands for AHR can be divided into three groups: host mediated, microbiota mediated, and dietary (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Natural ligands for aryl hydrocarbon receptor. Kynurenine (<italic>KYN</italic>) is converted from tryptophan in host metabolism. Kynurenic acid (<italic>KYNA</italic>) is also an AHR ligand, converted from KYN by kynurenine aminotransferase (<italic>KAT</italic>). There are three groups for microbiota-mediated AHR ligands: (1) tryptophan metabolites derived by microbiota, (2) bacterial virulence factors, and (3) short chain fatty acids. Short chain fatty acids are not direct ligands for AHR, but those facilitate AHR effects. Flavonoids, stilbenes, carotenoids, and indoles from plants are dietary ligands for AHR</p></caption><graphic id="MO1" xlink:href="109_2016_1486_Fig1_HTML"></graphic></fig>
</p>
<p>The essential amino acid tryptophan is the major source for both host-mediated and microbiome-mediated AHR ligands. Kynurenine (KYN) is converted from tryptophan by tryptophan 2,3-dioxygenase (TDO) or indoleamine 2,3-dioxygenase (IDO) and is an important AHR ligand [<xref ref-type="bibr" rid="CR44">44</xref>]. Kynurenic acid (KYNA) is converted from KYN by kynurenine aminotransferase and also an important ligand [<xref ref-type="bibr" rid="CR45">45</xref>]. Our research has shown that the microbiota regulates the expression of IDO in the liver, and although IDO may play a more important role in KYN metabolism in extrahepatic tissue [<xref ref-type="bibr" rid="CR46">46</xref>]. These results indicate a need to analyze the role of the microbiota in KYN metabolism [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
<p>Gut microbiota also converts tryptophan to indole, indole-3-acetate, and tryptamine, which have been identified in mouse and human intestine and work as AHR agonists and antagonists [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Microbial pigment virulence factors, namely the phenazines from microbes such as <italic>Pseudomonas aeruginosa</italic> and the naphthoquinone phthiocol from <italic>Mycobacterium tuberculosis</italic>, act as microbiota-mediated AHR ligands. Upon ligand binding, AHR activation leads to virulence factor degradation and regulates cytokine and chemokine production [<xref ref-type="bibr" rid="CR49">49</xref>]. Short chain fatty acids, such as propionic acid and butyrate, from the microbiome are not direct ligands for AHR, but our recent data suggest that they stabilize AHR, increasing its activity in the presence of true ligands (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Sodium butyrate (<italic>NaB</italic>) increase the activity of the aryl hydrocarbon receptor (<italic>AHR</italic>). HepG2 cells were cultured for 24 h with normal media or media containing NaB, beta-naphthoflavone (<italic>BNF</italic>), a natural agonist for AHR or NaB and BNF. While NaB not having a direct ligand effect on AHR demonstrated a significant synergistic effect to increase the activation of cyp1a by BNF</p></caption><graphic id="MO2" xlink:href="109_2016_1486_Fig2_HTML"></graphic></fig>
</p>
<p>The majority of dietary AHR ligands are produced by plants. Plant-derived compounds that act as ligands for AHR include flavonoids, stilbenes, carotenoids, and some indoles. Indole-3-carbiol (I3C) is an indole compound found in cruciferous vegetables that is converted to higher affinity AHR ligands, such as indolo-[3,2-b]-carbazole and 3,3′-diindolymethane in the acidic environment of the stomach [<xref ref-type="bibr" rid="CR50">50</xref>].</p>
</sec>
<sec id="Sec5">
<title>Microbiome and neurodevelopment</title>
<p>An important aspect of the functionality of the holobiont is the ability of each component to shape the behaviors of the others. Simply put, it behooves the microbiota to encourage certain “healthy” behaviors in the host. Although the effects of the microbiota are important in maintaining metabolism and the immune system, it is logical to conclude that the microbiota, acting in the best interests of the whole holobiont, may play a pivotal role in supporting the development of the central nervous system (CNS).</p>
<sec id="Sec6">
<title>The microbiota and neurodevelopment</title>
<p>Sudo et al. first demonstrated a possible link between the hypothalamic-pituitary-adrenal (HPA) axis and the gut microbiome [<xref ref-type="bibr" rid="CR51">51</xref>]. Elevated adrenocorticotropic hormone and corticosterone levels were observed in GF mice compared to specific pathogen-free (SPF) mice in early life. They also demonstrated that brain-derived neurotrophic factor (BDNF) is significantly reduced in the hippocampus and cortex of GF mice [<xref ref-type="bibr" rid="CR51">51</xref>]. Later studies confirmed regulation of steady state levels of BDNF by the microbiome [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], which plays an important role in neuroplasticity, neuron differentiation, and the maintenance and protection of neurons under stress. Many of these groups have linked changes in brain biochemistry to altered behaviors in GF mice [<xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR53">53</xref>].</p>
<p>Recently, there have been reports that the microbiome plays an important role in the growth and function of CNS cell populations. Hippocampal neurogenesis was shown to be increased in GF mice [<xref ref-type="bibr" rid="CR54">54</xref>], which also correlated to increased volume and abnormal neuronal morphology in the hippocampi of GF mice [<xref ref-type="bibr" rid="CR55">55</xref>]. Similarly, there was increased amygdala volume in GF mice with concomitant neuronal morphology [<xref ref-type="bibr" rid="CR55">55</xref>]. In contrast to this, hippocampal neurogenesis was shown to be decreased in mice treated with antibiotics [<xref ref-type="bibr" rid="CR56">56</xref>]. Möhle et al. demonstrated that their model of antibiotic depletion leads to decreased hippocampal neurogenesis through modulation of the populations of specific immune cells [<xref ref-type="bibr" rid="CR56">56</xref>]. Our group has also reported that the microbiome plays a key role in the maintenance of other synaptic proteins, including synaptophysin and PSD-95, both of which are reduced in the striatum of SPF mice, suggesting abnormally hyperactive synaptogenesis in the striatum of GF mice [<xref ref-type="bibr" rid="CR53">53</xref>]. The microbiome has also been implicated in the functionality of glial cells. Our group has demonstrated that the microbiota is instrumental in the development of the blood-brain barrier (BBB) [<xref ref-type="bibr" rid="CR57">57</xref>]. Finally, Hoban et al. demonstrated that in the absence of microbiota, there is increased myelination of neurons in the prefrontal cortex [<xref ref-type="bibr" rid="CR58">58</xref>].</p>
<p>Though these observations are of interest, knowledge on the molecular mechanisms linking the microbiome to neurodevelopment remains limited.</p>
</sec>
<sec id="Sec7">
<title>The aryl hydrocarbon receptor in neurodevelopment</title>
<p>Reports on the AHR in neurodevelopment are very limited. However, the AHR appears to be vital in the maintenance of some key pathways in neurodevelopment in worms. In <italic>Caenorhabditis elegans</italic>, Huang et al. demonstrated a role for AHR in neural cell fate determination, particularly for GABAergic neurons [<xref ref-type="bibr" rid="CR59">59</xref>]. AHR-1 is the AHR orthologue in <italic>C</italic>. <italic>elegans</italic>. In worms with AHR-1 mutations, two specific neurons out of the 302 total neurons have been reported to appear and act like a second pair of neurons that could be reprogrammed into the first pair of neurons by ectopic administration of AHR-1 [<xref ref-type="bibr" rid="CR59">59</xref>]. In addition, Qin et al. found that AHR-1 is responsible for the development, orientation, and axonal migration of AHR-1-expressing neurons in <italic>C</italic>. <italic>elegans</italic> [<xref ref-type="bibr" rid="CR60">60</xref>]. Taken together, these results demonstrate that AHR contributes to the cell fate determination of specific neuronal populations in worms, possibly through natural ligands and irrespective of dioxin exposure.</p>
<p>Dioxin toxicity studies have demonstrated that the AHR is likely to play a role in CNS development. In zebrafish, TCDD exposure was reported to reduce the total number of neurons by 30% [<xref ref-type="bibr" rid="CR61">61</xref>]. In mice, dioxin toxicity studies have demonstrated a similar role for AHR in the embryonic differentiation of GABAergic neurons in the telencephalon [<xref ref-type="bibr" rid="CR62">62</xref>] and the neurogenesis of cerebellar granule cells [<xref ref-type="bibr" rid="CR63">63</xref>]. Importantly, due to the extraordinarily high binding affinity of dioxin for the AHR, emphatic conclusions regarding the physiological role of the AHR in normal development cannot be drawn from dioxin studies alone.</p>
<p>The AHR was also shown to play a crucial role in CNS development in studies more consistent with typical biology. The expression of a constitutively active AHR in mice retarded the development of interneurons in the olfactory bulb [<xref ref-type="bibr" rid="CR64">64</xref>]. Furthermore, in mouse primary cortical neurons, AHR activation by FICZ was also shown to increase the expression of synaptophysin and SAP102, but not PSD95 [<xref ref-type="bibr" rid="CR65">65</xref>]. In functional experiments, the AHR was shown to alter hippocampal neurogenesis and contextual fear memory in mice [<xref ref-type="bibr" rid="CR66">66</xref>], as well as aggression behavior in <italic>C. elegans</italic> [<xref ref-type="bibr" rid="CR67">67</xref>]. Latchney et al. demonstrated that adult AHR-KO mice and TCDD-exposed mice hippocampal-dependent memory impairment. AHR-deficient mice and TCDD-exposed mice also exhibited reduced cell proliferation, survival, and differentiation in the adult dentate gyrus [<xref ref-type="bibr" rid="CR66">66</xref>]. The often conflicting data demonstrating both the KO and activation of AHR lead to similar outcomes, suggesting that the AHR plays a vital role in CNS homeostasis.</p>
</sec>
<sec id="Sec8">
<title>Autism spectrum disorder</title>
<p>Autism spectrum disorder (ASD) is a neurodevelopmental illness for which evidence supports a possible link between the maternal/early postnatal microbiome and dysfunctional neurodevelopmental programming. From a human health perspective, the association between the microbiome and neurodevelopment was highlighted by evidence that people suffering from ASD also frequently present with problems related to a dysfunctional bowel with aberrant intestinal barrier function [<xref ref-type="bibr" rid="CR68">68</xref>]. Although the association remains controversial, a role for dysfunctional microbiome-gut-brain axis has gained further support from the recent demonstration of different microbiome composition in children with ASD compared to age-matched controls [<xref ref-type="bibr" rid="CR69">69</xref>].</p>
<p>A recent study demonstrated that, in an animal model of ASD, correction of the microbiota with probiotic administration of <italic>Bacteroides fragilis</italic> corrected biochemical and behavioral abnormalities associated with ASD [<xref ref-type="bibr" rid="CR70">70</xref>]. In this ASD mouse model, the key effector in the microbiota-gut-brain axis was the metabolome; a number of specific metabolites altered in the ASD mouse model were normalized by the treatment. Indolepyruvate, a microbially controlled molecule that is metabolized into an AHR agonist, was significantly regulated in the ASD model and by <italic>B. fragilis</italic> treatment [<xref ref-type="bibr" rid="CR70">70</xref>]. This metabolite is an interesting corollary to indolyl-3-acryloylglycine, which has been shown to be elevated in the urine of humans with ASD [<xref ref-type="bibr" rid="CR71">71</xref>].</p>
<p>Epidemiological studies of Vietnamese children exposed to TCDD in the prenatal and perinatal period have demonstrated increased neurodevelopmental defects and autistic traits in children with greater exposure to TCDD [<xref ref-type="bibr" rid="CR72">72</xref>]. Prenatal and postnatal exposure to KYN in rats causes cognitive defects in adulthood [<xref ref-type="bibr" rid="CR73">73</xref>]. Although Pocivavsek et al. did not identify a specific mechanism underlying the association between early life KYN exposure and cognitive deficits, they did note that the treatment led to 3.4- and 2.1-fold increases in KYNA levels in the brain at postnatal days 2 and 21, respectively [<xref ref-type="bibr" rid="CR73">73</xref>]. Although Pocivavsek et al. noted the effects of KYNA as an antagonist of the α7 nicotinic acetylcholine receptor and the N-methyl-d-aspartate receptor [<xref ref-type="bibr" rid="CR73">73</xref>], KYNA is also an AHR ligand with a stronger binding affinity for the AHR than KYN [<xref ref-type="bibr" rid="CR45">45</xref>], potentially implicating AHR activity in the cognitive abnormalities observed in this model.</p>
<p>An animal model of ASD appearing to be caused, in part, by microbial metabolites that act on the AHR and epidemiological studies linking environmental exposure to AHR ligands to neurodevelopmental issues and strong associations between ASD and gastrointestinal pathology suggest that ASD is a systems biology problem within the holobiont. Therefore, the AHR signaling pathway and its microbially derived natural ligands are of great interest for further exploration of ASD and other neurodevelopmental disorders.</p>
</sec>
</sec>
<sec id="Sec9">
<title>Neurodegeneration</title>
<p>Neurodegeneration is regarded as a pathological process, whereby neuron loss is increased frequently in association with aging. The mechanisms underpinning neurodegeneration and neuron loss are poorly understood, but are assumed to be the result of a metabolic dysfunction, increased autophagy, and aberrant host immune system activity.</p>
<p>Irritable bowel syndrome (IBS), an illness associated with disruption of the microbiota, has been shown to be a risk factor for Parkinson’s disease [<xref ref-type="bibr" rid="CR74">74</xref>] and both non-Alzheimer’s disease dementia and Alzheimer’s disease [<xref ref-type="bibr" rid="CR75">75</xref>]. Our group also recently showed that IBS may precede glaucoma, a progressive neurodegeneration of the optic nerve, in two primarily Caucasian populations [<xref ref-type="bibr" rid="CR76">76</xref>]. These results provide evidence that pathological mechanisms underlying IBS, including disruption of the microbiota, may have clinically relevant effects in neurodegenerative illnesses and alter homeostatic mechanisms in the CNS. Moreover, tryptophan metabolism by the microbiota has been suggested to play a role in IBS pathology through AHR-mediated pathways [<xref ref-type="bibr" rid="CR77">77</xref>].</p>
<p>Parkinson’s disease, which has long been known to be associated with gastrointestinal dysfunction, has been theorized to be initiated within the gut and follow a prion-like spread of pathology through the vagus nerve into the brain [<xref ref-type="bibr" rid="CR78">78</xref>]. The effects of microbiome-driven inflammation on Parkinson’s pathology were assessed by orally administering bacterial lipopolysaccharide, which caused a rapid increase in alpha synuclein expression in the myenteric neurons of the mouse gut [<xref ref-type="bibr" rid="CR79">79</xref>]. In humans, Parkinson’s disease is associated with alterations in the microbiota, particularly as regards to <italic>Prevotella</italic> and Enterobacteria [<xref ref-type="bibr" rid="CR80">80</xref>].</p>
<p>Finally, an interesting preprint article has demonstrated that the microbiome may play a role in the formation of beta-amyloid plaques in the mouse brain. GF Alzheimer’s transgenic mice demonstrated significantly lower levels of beta-amyloid in the brain than conventionally raised transgenic mice. Moreover, the fecal 16S RNA analysis showed that Alzheimer’s transgenic mice had a significantly different microbiome to wild type mice and fecal transplants from transgenic mice, but not wild type mice was able to significantly upregulate the beta-amyloid in the brains of germ-free Alzheimer’s transgenic mice [<xref ref-type="bibr" rid="CR81">81</xref>].</p>
<p>The assessment of the microbiota in patients with neurodegenerative illnesses is ongoing.</p>
<sec id="Sec10">
<title>The blood-brain barrier</title>
<p>The AHR is widely expressed in the CNS [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. However, our understanding of the role of the AHR in neurons and supporting cells is still very limited. The BBB is vitally important in the maintenance of CNS homeostasis, and its weakening has been suggested to contribute to neurodegenerative pathology. Breakdown of the BBB at the hippocampus has been correlated with cognitive impairment in humans [<xref ref-type="bibr" rid="CR84">84</xref>]. Previously, our group reported that the BBB exhibits increased permeability in adult GF mice [<xref ref-type="bibr" rid="CR57">57</xref>]. Monocolonization with <italic>Clostridium tyrobutyricum</italic> or <italic>Bacteroides thetaiotaomicron</italic> and treatment with sodium butyrate had rescuing effects on BBB permeability and tight junction protein expression [<xref ref-type="bibr" rid="CR57">57</xref>]. One mechanism of the microbiome-mediated effects on BBB permeability appeared to be related to changes in the expression of tight junction proteins, such as occludin and claudin-5 [<xref ref-type="bibr" rid="CR57">57</xref>]. A recent report demonstrated that induction of dysbiosis with a mixture of antibiotics caused alterations in the mRNA expression of tight junction proteins in the brain [<xref ref-type="bibr" rid="CR85">85</xref>], validating, at an mRNA level, the results produced by Braniste et al. in a separate model of microbiome disruption.</p>
<p>The presence of the AHR and expression of its target genes have been shown to be significantly elevated in the microvessels of the brain [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. Contradictory results have been reported. Via activation by TCDD, the AHR decreases the permeability of the BBB in vivo [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>], but increased BBB permeability was observed following exposure to 3-methylcholanthrene [<xref ref-type="bibr" rid="CR89">89</xref>]. Interestingly, though the increased BBB permeability reported by Braniste et al. has not been assessed in the context of the AHR, a recent study in keratinocytes demonstrated that ligand activation of the AHR elevates occludin and claudin 1 and 4 [<xref ref-type="bibr" rid="CR90">90</xref>], indicating that a similar AHR-mediated effect could occur in the BBB. One of the most abundant gap junction proteins in the BBB is connexin 43. Connexin 43 expression and gap junction integrity has been shown to be downregulated by AHR activation [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. The deletion of connexin 43 is known to weaken the BBB, allowing it to open under increased vascular hydrostatic pressure or shear stress [<xref ref-type="bibr" rid="CR93">93</xref>]. A recent report suggested that connexin 43 is integral to brain immune quiescence [<xref ref-type="bibr" rid="CR94">94</xref>] and, irrespective of BBB integrity, the deletion of connexin 43 was associated with increased immune cell recruitment across the BBB. Moreover, deletion of connexin 43 leads to activation of the endothelium and chemoattraction, thereby linking a key molecule in the maintenance of BBB integrity with the neuroinflammatory response [<xref ref-type="bibr" rid="CR94">94</xref>].</p>
</sec>
<sec id="Sec11">
<title>Neuroinflammation</title>
<p>The role of the AHR in the immune system is being increasingly appreciated [<xref ref-type="bibr" rid="CR95">95</xref>], and the role of neuroinflammation in psychiatric diseases is also being recognized [<xref ref-type="bibr" rid="CR96">96</xref>]. One of the hallmarks of neuroinflammation that potentially impacts the neuropsychiatric phenotype [<xref ref-type="bibr" rid="CR97">97</xref>] and neurodegenerative pathology [<xref ref-type="bibr" rid="CR98">98</xref>] is the chronic activation of microglia. GF mice have immature microglia with unusual activation properties [<xref ref-type="bibr" rid="CR99">99</xref>]. Furthermore, microglia from GF mice have altered gene expression profiles similar to the SOD1 mouse model of amyotrophic lateral sclerosis [<xref ref-type="bibr" rid="CR100">100</xref>]. Although some of the GF microglial phenotypes could be rescued by short chain fatty acid supplementation [<xref ref-type="bibr" rid="CR99">99</xref>], this does not preclude the possibility of microbiotic interactions through alternate pathways, including the AHR.</p>
<p>AHR mediates both pro-inflammatory and anti-inflammatory effects in microglia [<xref ref-type="bibr" rid="CR101">101</xref>]. Lee et al. found that AHR activation with FICZ and 3-methylcholanthrene attenuates microglial immune responses. They also demonstrated that silencing the AHR gene with siRNA reduces microglial activation, demonstrating a pro-inflammatory effect of the AHR [<xref ref-type="bibr" rid="CR101">101</xref>]. Other groups have found similar pro-inflammatory and anti-inflammatory effects of the AHR. Within the CNS of AHR-null mice, microglia accumulate in the retina in a model of age-related macular degeneration [<xref ref-type="bibr" rid="CR102">102</xref>].</p>
<p>Dietary and microbiotic metabolites, particularly tryptophan metabolites [<xref ref-type="bibr" rid="CR12">12</xref>], may play an important anti-inflammatory role in the CNS. FICZ was recently shown to modulate astrocyte activity and CNS inflammation through the AHR [<xref ref-type="bibr" rid="CR103">103</xref>], thereby linking the microbiota directly to neuroinflammatory mechanisms through the AHR. Astrocytes are the most abundant glial cell population in the CNS, participating in metabolism, neuronal transmission, and inflammation [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. In a mouse model of CNS autoimmunity, CNS inflammation induced a type 1 interferon-mediated response in astrocytes, which induced AHR activation [<xref ref-type="bibr" rid="CR103">103</xref>]. This AHR response was shown to limit astrocyte inflammation and was increasingly efficacious when mice were supplied dietary tryptophan. To demonstrate that the effects were due to microbiota-mediated metabolism of tryptophan, ampicillin (a broad spectrum antibiotic) was given, which interfered with the effects of dietary tryptophan, and the treatment of mice directly with indoxyl-3-sulfate (a microbial metabolite of tryptophan) led to AHR-mediated anti-inflammatory effects [<xref ref-type="bibr" rid="CR103">103</xref>]. The dietary metabolite and AHR ligand indirubin-3′-oxime were also shown to inhibit the inflammatory activation of microglia in the rat brain [<xref ref-type="bibr" rid="CR106">106</xref>]. Whether the immune system regulatory systems exhibited by the AHR in the periphery are relevant to neuroinflammatory responses is not clear. Moreover, as different ligands have different effects on the transcriptional effects of the AHR, the effects of endogenous and exogenous AHR ligands require deep investigation to further elucidate the varying effects of the receptor in the regulation of neuroinflammation.</p>
<p>The pro-inflammatory and anti-inflammatory effects of the AHR are likely due to the complex interactions the receptor can have with other transcription factors. For example, the pro-inflammatory cytokine TNF-alpha is upregulated when microglia are stimulated by lipopolysaccharide, but this effect is attenuated both when the AHR is activated by FICZ and when the AHR is silenced by siRNA due to the complex interactions between the receptor and NF-κB, which can be modulated by the application of AHR ligands [<xref ref-type="bibr" rid="CR101">101</xref>]. Similarly, Rothhammer et al. found that the AHR-mediated anti-inflammatory effects in astrocytes are due to the limitation of NF-κB activation [<xref ref-type="bibr" rid="CR103">103</xref>].</p>
</sec>
<sec id="Sec12">
<title>Ischemic stroke</title>
<p>One interesting neurodegenerative process clearly regulated by the microbiota and microbiota-metabolized AHR ligands is ischemic neurodegeneration. In three separate mouse models of microbiota disruption, the microbiota was shown to impact the outcome of ischemic stroke [<xref ref-type="bibr" rid="CR107">107</xref>–<xref ref-type="bibr" rid="CR109">109</xref>]. Depletion of the microbiota with a cocktail of antibiotics decreased survival in a middle cerebral artery occlusion (MCAO) model of murine stroke and severe colitis in mice after stroke. Interestingly, that study found no significant difference in infarct size 1 day after stroke [<xref ref-type="bibr" rid="CR107">107</xref>]. In a separate model in which the microbiota of mice was altered, not depleted, with amoxicillin and clavulanic acid, infarct volume was significantly reduced compared to mice with a healthy microbiota [<xref ref-type="bibr" rid="CR108">108</xref>]. This microbiota-stroke effect may be bidirectional, as Singh et al. demonstrated that particularly large infarcts can cause dysbiosis within the microbiota, possibly potentiating neuroinflammatory effects within the CNS [<xref ref-type="bibr" rid="CR109">109</xref>]. Benakis et al. demonstrated that intestinal IL-17<sup>+</sup> γδ T cells, which were reduced in their model of dysbiosis, accumulate in the meninges after stroke and are responsible for a neuroinflammatory response that potentiates damage after ischemic insult [<xref ref-type="bibr" rid="CR108">108</xref>]. Interestingly, the AHR alters the function of γδ T cells and its stimulation with FICZ elevates IL-17 production in these cells [<xref ref-type="bibr" rid="CR110">110</xref>]. In human illness, elevated serum levels of KYNA during the acute phase of stroke have been correlated with worse neuropsychiatric outcomes in stroke patients [<xref ref-type="bibr" rid="CR111">111</xref>]. Similarly, IDO activity, as determined by the KYN to tryptophan ratio, is positively associated with stroke severity [<xref ref-type="bibr" rid="CR112">112</xref>], and other elements of the KYN metabolic pathway have been correlated with infarct size in stroke [<xref ref-type="bibr" rid="CR113">113</xref>]. To evaluate the specific role of the AHR in stroke, Cuartero et al. used the MCAO stroke model to demonstrate that the receptor is upregulated and activated after ischemic insult [<xref ref-type="bibr" rid="CR114">114</xref>]. Pharmacological inhibition of the AHR resulted in a smaller infarct size and greater functional outcomes, and stimulation of the AHR resulted in increased infarct volume [<xref ref-type="bibr" rid="CR114">114</xref>]. KYN levels in the brain were also elevated in this model of stroke and, through activation of the AHR, played a deleterious role in cerebral ischemia [<xref ref-type="bibr" rid="CR114">114</xref>]. How the microbiota interacts with tryptophan metabolism to affect the AHR in neural ischemia is still unknown.</p>
</sec>
</sec>
</sec>
<sec id="Sec13">
<title>Summary and further directions</title>
<p>As mounting evidence supports the holobiont model of the host and its microbiome, one of the most important questions that the researchers are facing is the mechanisms by which the microbiota communicates with the host. The AHR is an evolutionarily conserved ligand-induced receptor involved in host-environment interactions. Despite its well-known responsiveness to man-made compounds, such as TCDD, in invertebrates, the AHR does not elicit a response to dioxin. Therefore, AHR must execute other evolutionarily important roles in development and homeostasis. Interestingly, we and others have found that AHR responds to microbiome-mediated ligands engaging host immune and metabolic responses. Moreover, many AHR ligands cross the BBB, implying a role of AHR in the CNS (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). While preparing this review, we have realized that there are much more to be learned about the AHR signaling pathway and its impact on CNS development and function. The pleiotropic action of AHR and its wide expression pattern may also hold hope for the development of new microbiome derived compounds that support the metabolic homeostasis within the holobiont.<fig id="Fig3"><label>Fig. 3</label><caption><p>Proposed model. The activities of the microbiota through the aryl hydrocarbon receptor (<italic>AHR</italic>) on the central nervous system</p></caption><graphic id="MO3" xlink:href="109_2016_1486_Fig3_HTML"></graphic></fig>
</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>Hae Ung Lee and Zachary E. McPherson are the first coauthors.</p>
</fn>
</fn-group>
<ack>
<p>The authors wish to thank Dr. Ruchi Agrawal for proofreading the manuscript. This project was supported by MOE AcRF Tier 1 (1T1-04/15), MOE START-UP Grant (SUG), Singapore Centre on Environmental Life Sciences Engineering (SCELSE), NTU and ZM is supported by a scholarship from the Barker Family and the Jennie Thomas Medical Research Travel Grant.</p>
</ack>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<sec id="FPar1">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maloof</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Beach</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Samuels</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Calmet</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Erwin</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Poirier</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Simons</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Possible animal-body fossils in pre-Marinoan limestones from South Australia</article-title>
<source/>Nature Geosci
          <year>2010</year>
<volume>3</volume>
<fpage>653</fpage>
<lpage>659</lpage>
<pub-id pub-id-type="doi">10.1038/ngeo934</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Boehnke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>WL</given-names>
</name>
</person-group>
<article-title>Potentially biogenic carbon preserved in a 4.1 billion-year-old zircon</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2015</year>
<volume>112</volume>
<fpage>14518</fpage>
<lpage>14521</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1517557112</pub-id>
<pub-id pub-id-type="pmid">26483481</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kinross</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burcelin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Host-gut microbiota metabolic interactions</article-title>
<source/>Science
          <year>2012</year>
<volume>336</volume>
<fpage>1262</fpage>
<lpage>1267</lpage>
<pub-id pub-id-type="doi">10.1126/science.1223813</pub-id>
<pub-id pub-id-type="pmid">22674330</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linden</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lensu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tuomisto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pohjanvirta</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance</article-title>
<source/>Front Neuroendocrinol
          <year>2010</year>
<volume>31</volume>
<fpage>452</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2010.07.002</pub-id>
<pub-id pub-id-type="pmid">20624415</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denison</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals</article-title>
<source/>Annu Rev Pharmacol Toxicol
          <year>2003</year>
<volume>43</volume>
<fpage>309</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.pharmtox.43.100901.135828</pub-id>
<pub-id pub-id-type="pmid">12540743</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sorrentino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Denison</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kolaja</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fielden</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro</article-title>
<source/>Mol Pharmacol
          <year>2007</year>
<volume>71</volume>
<fpage>1475</fpage>
<lpage>1486</lpage>
<pub-id pub-id-type="doi">10.1124/mol.106.032748</pub-id>
<pub-id pub-id-type="pmid">17327465</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Perdew</surname>
<given-names>GH</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor ligands in cancer: friend and foe</article-title>
<source/>Nat Rev Cancer
          <year>2014</year>
<volume>14</volume>
<fpage>801</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="doi">10.1038/nrc3846</pub-id>
<pub-id pub-id-type="pmid">25568920</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diani-Moore</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Mondal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Youn</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Sauve</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Rifkind</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect</article-title>
<source/>J Biol Chem
          <year>2010</year>
<volume>285</volume>
<fpage>38801</fpage>
<lpage>38810</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.131573</pub-id>
<pub-id pub-id-type="pmid">20876576</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Baldwin</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Renzelli</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>McDaniel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>TCDD-inducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin</article-title>
<source/>Biochem Biophys Res Commun
          <year>2001</year>
<volume>289</volume>
<fpage>499</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.2001.5987</pub-id>
<pub-id pub-id-type="pmid">11716501</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Hanieh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakahama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kishimoto</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The roles of aryl hydrocarbon receptor in immune responses</article-title>
<source/>Int Immunol
          <year>2013</year>
<volume>25</volume>
<fpage>335</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1093/intimm/dxt011</pub-id>
<pub-id pub-id-type="pmid">23580432</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opitz</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Litzenburger</surname>
<given-names>UM</given-names>
</name>
<name>
<surname>Sahm</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ott</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tritschler</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Trump</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jestaedt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schrenk</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weller</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor</article-title>
<source/>Nature
          <year>2011</year>
<volume>478</volume>
<fpage>197</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1038/nature10491</pub-id>
<pub-id pub-id-type="pmid">21976023</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Di Meglio</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gialitakis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>The aryl hydrocarbon receptor: multitasking in the immune system</article-title>
<source/>Annu Rev Immunol
          <year>2014</year>
<volume>32</volume>
<fpage>403</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120245</pub-id>
<pub-id pub-id-type="pmid">24655296</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hahn</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Karchner</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1997</year>
<volume>94</volume>
<fpage>13743</fpage>
<lpage>13748</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.25.13743</pub-id>
<pub-id pub-id-type="pmid">9391097</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hahn</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptors: diversity and evolution</article-title>
<source/>Chem Biol Interact
          <year>2002</year>
<volume>141</volume>
<fpage>131</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1016/S0009-2797(02)00070-4</pub-id>
<pub-id pub-id-type="pmid">12213389</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Whitelaw</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>The emerging roles of AhR in physiology and immunity</article-title>
<source/>Biochem Pharmacol
          <year>2013</year>
<volume>86</volume>
<fpage>561</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2013.07.004</pub-id>
<pub-id pub-id-type="pmid">23856287</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quintana</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Basso</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Korn</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Farez</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Bettelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Caccamo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oukka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Control of Treg and Th17 cell differentiation by the aryl hydrocarbon receptor</article-title>
<source/>Nature
          <year>2008</year>
<volume>453</volume>
<fpage>65</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1038/nature06880</pub-id>
<pub-id pub-id-type="pmid">18362915</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Salguero</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pineau</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hilbert</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>McPhail</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nebert</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Rudikoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor</article-title>
<source/>Science
          <year>1995</year>
<volume>268</volume>
<fpage>722</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="doi">10.1126/science.7732381</pub-id>
<pub-id pub-id-type="pmid">7732381</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benedict</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Loeffler</surname>
<given-names>IK</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Flaws</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Physiological role of the aryl hydrocarbon receptor in mouse ovary development</article-title>
<source/>Toxicol Sci
          <year>2000</year>
<volume>56</volume>
<fpage>382</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/56.2.382</pub-id>
<pub-id pub-id-type="pmid">10910997</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Bradfield</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>The search for endogenous activators of the aryl hydrocarbon receptor</article-title>
<source/>Chem Res Toxicol
          <year>2008</year>
<volume>21</volume>
<fpage>102</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1021/tx7001965</pub-id>
<pub-id pub-id-type="pmid">18076143</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<mixed-citation publication-type="other">Korecka A, Dona A, Lahiri SK, Tett AJ, Al-Asmakh M, Braniste V, D’Arienzo R, Abbaspour A, Reichardt N, Fujii-Kuriyama Y et al. (2016) Bidirectional communication between the Aryl-hydrocarbon-Receptor (AhR) and the gut microbiome tunes host metabolism npj Biofilms and Microbiomes (In Press)</mixed-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Remillard</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Bunce</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Linking dioxins to diabetes: epidemiology and biologic plausibility</article-title>
<source/>Environ Health Perspect
          <year>2002</year>
<volume>110</volume>
<fpage>853</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.02110853</pub-id>
<pub-id pub-id-type="pmid">12204817</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Garbacz</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21</article-title>
<source/>Hepatology
          <year>2015</year>
<volume>61</volume>
<fpage>1908</fpage>
<lpage>1919</lpage>
<pub-id pub-id-type="doi">10.1002/hep.27719</pub-id>
<pub-id pub-id-type="pmid">25614121</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Febbraio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Matsubara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis</article-title>
<source/>Gastroenterology
          <year>2010</year>
<volume>139</volume>
<fpage>653</fpage>
<lpage>663</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2010.03.033</pub-id>
<pub-id pub-id-type="pmid">20303349</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabot</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Membrez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gerard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Harach</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mansourian</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Germ-free C57BL/6 J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism</article-title>
<source/>FASEB J
          <year>2010</year>
<volume>24</volume>
<fpage>4948</fpage>
<lpage>4959</lpage>
<pub-id pub-id-type="doi">10.1096/fj.10-164921</pub-id>
<pub-id pub-id-type="pmid">20724524</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backhed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Manchester</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Semenkovich</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Mechanisms underlying the resistance to diet-induced obesity in germ-free mice</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2007</year>
<volume>104</volume>
<fpage>979</fpage>
<lpage>984</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0605374104</pub-id>
<pub-id pub-id-type="pmid">17210919</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>CX</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>ZM</given-names>
</name>
<name>
<surname>Jaeger</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Krager</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Bottum</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Tischkau</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure</article-title>
<source/>Int J Obes
          <year>2015</year>
<volume>39</volume>
<fpage>1300</fpage>
<lpage>1309</lpage>
<pub-id pub-id-type="doi">10.1038/ijo.2015.63</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badman</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Pissios</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Koukos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Flier</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Maratos-Flier</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states</article-title>
<source/>Cell Metab
          <year>2007</year>
<volume>5</volume>
<fpage>426</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2007.05.002</pub-id>
<pub-id pub-id-type="pmid">17550778</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inagaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dutchak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gautron</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Parameswara</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Goetz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Esser</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21</article-title>
<source/>Cell Metab
          <year>2007</year>
<volume>5</volume>
<fpage>415</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2007.05.003</pub-id>
<pub-id pub-id-type="pmid">17550777</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Klaassen</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis</article-title>
<source/>Toxicol Appl Pharmacol
          <year>2011</year>
<volume>256</volume>
<fpage>122</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2011.07.019</pub-id>
<pub-id pub-id-type="pmid">21846477</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kharitonenkov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shiyanova</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Koester</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Micanovic</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Galbreath</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Sandusky</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Moyers</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FGF-21 as a novel metabolic regulator</article-title>
<source/>J Clin Invest
          <year>2005</year>
<volume>115</volume>
<fpage>1627</fpage>
<lpage>1635</lpage>
<pub-id pub-id-type="doi">10.1172/JCI23606</pub-id>
<pub-id pub-id-type="pmid">15902306</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coskun</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bina</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Dunbar</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Kharitonenkov</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fibroblast growth factor 21 corrects obesity in mice</article-title>
<source/>Endocrinology
          <year>2008</year>
<volume>149</volume>
<fpage>6018</fpage>
<lpage>6027</lpage>
<pub-id pub-id-type="doi">10.1210/en.2008-0816</pub-id>
<pub-id pub-id-type="pmid">18687777</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Vispute</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kharitonenkov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Klaassen</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR)</article-title>
<source/>Toxicol Appl Pharmacol
          <year>2014</year>
<volume>278</volume>
<fpage>65</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2014.04.013</pub-id>
<pub-id pub-id-type="pmid">24769090</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gandhi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Nadeau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dake</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Laroni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kozoriz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Quintana</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells</article-title>
<source/>Nat Immunol
          <year>2010</year>
<volume>11</volume>
<fpage>846</fpage>
<lpage>853</lpage>
<pub-id pub-id-type="doi">10.1038/ni.1915</pub-id>
<pub-id pub-id-type="pmid">20676092</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Naka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakahama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chinen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nohara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fujii-Kuriyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kishimoto</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses</article-title>
<source/>J Exp Med
          <year>2009</year>
<volume>206</volume>
<fpage>2027</fpage>
<lpage>2035</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20090560</pub-id>
<pub-id pub-id-type="pmid">19703987</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quintana</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Murugaiyan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Farez</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Mitsdoerffer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tukpah</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>20768</fpage>
<lpage>20773</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1009201107</pub-id>
<pub-id pub-id-type="pmid">21068375</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veldhoen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O’Garra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells</article-title>
<source/>J Exp Med
          <year>2009</year>
<volume>206</volume>
<fpage>43</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20081438</pub-id>
<pub-id pub-id-type="pmid">19114668</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veldhoen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Westendorf</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Buer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dumoutier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Renauld</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The aryl hydrocarbon receptor links Th17-cell-mediated autoimmunity to environmental toxins</article-title>
<source/>Nature
          <year>2008</year>
<volume>453</volume>
<fpage>106</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1038/nature06881</pub-id>
<pub-id pub-id-type="pmid">18362914</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vorderstrasse</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Bohn</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>BP</given-names>
</name>
</person-group>
<article-title>Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD</article-title>
<source/>Toxicology
          <year>2003</year>
<volume>188</volume>
<fpage>15</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/S0300-483X(02)00749-7</pub-id>
<pub-id pub-id-type="pmid">12748038</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>BP</given-names>
</name>
</person-group>
<article-title>Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung</article-title>
<source/>Toxicol Sci
          <year>2000</year>
<volume>56</volume>
<fpage>114</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/56.1.114</pub-id>
<pub-id pub-id-type="pmid">10869459</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Winans</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>BP</given-names>
</name>
</person-group>
<article-title>New insights into the role of the aryl hydrocarbon receptor in the function of CD11c(+) cells during respiratory viral infection</article-title>
<source/>Eur J Immunol
          <year>2014</year>
<volume>44</volume>
<fpage>1685</fpage>
<lpage>1698</lpage>
<pub-id pub-id-type="doi">10.1002/eji.201343980</pub-id>
<pub-id pub-id-type="pmid">24519489</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Horimoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kameyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamato</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dazai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kida</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bott</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense</article-title>
<source/>Nat Immunol
          <year>2016</year>
<volume>17</volume>
<fpage>687</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="doi">10.1038/ni.3422</pub-id>
<pub-id pub-id-type="pmid">27089381</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chng</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dominguez-Brauer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Teo</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Kawajiri</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fujii-Kuriyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Ablating the aryl hydrocarbon receptor (AhR) in CD11c + cells perturbs intestinal epithelium development and intestinal immunity</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>23820</fpage>
<pub-id pub-id-type="doi">10.1038/srep23820</pub-id>
<pub-id pub-id-type="pmid">27068235</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duarte</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Di Meglio</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ahlfors</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e79819</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0079819</pub-id>
<pub-id pub-id-type="pmid">24244565</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mezrich</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Fechner</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Burlingham</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Bradfield</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells</article-title>
<source/>J Immunol
          <year>2010</year>
<volume>185</volume>
<fpage>3190</fpage>
<lpage>3198</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0903670</pub-id>
<pub-id pub-id-type="pmid">20720200</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiNatale</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Flaveny</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Lahoti</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Laurenzana</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Omiecinski</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Perdew</surname>
<given-names>GH</given-names>
</name>
</person-group>
<article-title>Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling</article-title>
<source/>Toxicol Sci
          <year>2010</year>
<volume>115</volume>
<fpage>89</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfq024</pub-id>
<pub-id pub-id-type="pmid">20106948</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badawy</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements</article-title>
<source/>Neuropharmacology
          <year>2015</year>
<pub-id pub-id-type="pmid">26617070</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>UH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Sridharan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Jayaraman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chapkin</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Alaniz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Safe</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities</article-title>
<source/>Mol Pharmacol
          <year>2014</year>
<volume>85</volume>
<fpage>777</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.1124/mol.113.091165</pub-id>
<pub-id pub-id-type="pmid">24563545</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubbard</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Bisson</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Lahoti</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Gowda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Perdew</surname>
<given-names>GH</given-names>
</name>
</person-group>
<article-title>Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>12689</fpage>
<pub-id pub-id-type="doi">10.1038/srep12689</pub-id>
<pub-id pub-id-type="pmid">26235394</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moura-Alves</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fae</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Houthuys</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dorhoi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kreuchwig</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Furkert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barison</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Diehl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Munder</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Constant</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>AhR sensing of bacterial pigments regulates antibacterial defence</article-title>
<source/>Nature
          <year>2014</year>
<volume>512</volume>
<fpage>387</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1038/nature13684</pub-id>
<pub-id pub-id-type="pmid">25119038</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shertzer</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Senft</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>The micronutrient indole-3-carbinol: implications for disease and chemoprevention</article-title>
<source/>Drug Metabol Drug Interact
          <year>2000</year>
<volume>17</volume>
<fpage>159</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1515/DMDI.2000.17.1-4.159</pub-id>
<pub-id pub-id-type="pmid">11201294</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sonoda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>XN</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Koga</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>
<source/>J Physiol
          <year>2004</year>
<volume>558</volume>
<fpage>263</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id>
<pub-id pub-id-type="pmid">15133062</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bercik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Denou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jury</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Blennerhassett</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Macri</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice</article-title>
<source/>Gastroenterology
          <year>2011</year>
<volume>141</volume>
<fpage>599</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2011.04.052</pub-id>
<pub-id pub-id-type="pmid">21683077</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz Heijtz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bjorkholm</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Samuelsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hibberd</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Forssberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>108</volume>
<fpage>3047</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id>
<pub-id pub-id-type="pmid">21282636</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogbonnaya</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
<collab>O’Leary OF</collab>
</person-group>
<article-title>Adult hippocampal neurogenesis is regulated by the microbiome</article-title>
<source/>Biol Psychiatry
          <year>2015</year>
<volume>78</volume>
<fpage>e7</fpage>
<lpage>e9</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.12.023</pub-id>
<pub-id pub-id-type="pmid">25700599</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luczynski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Whelan</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Adult microbiota-deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus</article-title>
<source/>Eur J Neurosci
          <year>2016</year>
<pub-id pub-id-type="pmid">27256072</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohle</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mattei</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Heimesaat</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Bereswill</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alutis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>French</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hambardzumyan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Matzinger</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dunay</surname>
<given-names>IR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis</article-title>
<source/>Cell Rep
          <year>2016</year>
<volume>15</volume>
<fpage>1945</fpage>
<lpage>1956</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.074</pub-id>
<pub-id pub-id-type="pmid">27210745</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braniste</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Al-Asmakh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kowal</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Abbaspour</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Korecka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bakocevic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>
<source/>Sci Transl Med
          <year>2014</year>
<volume>6</volume>
<fpage>263ra158</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3009759</pub-id>
<pub-id pub-id-type="pmid">25411471</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoban</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Claesson</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Regulation of prefrontal cortex myelination by the microbiota</article-title>
<source/>Transl Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e774</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.42</pub-id>
<pub-id pub-id-type="pmid">27045844</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Powell-Coffman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in <italic>C. elegans</italic></article-title>
<source/>Development
          <year>2004</year>
<volume>131</volume>
<fpage>819</fpage>
<lpage>828</lpage>
<pub-id pub-id-type="doi">10.1242/dev.00959</pub-id>
<pub-id pub-id-type="pmid">14757639</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Powell-Coffman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The <italic>Caenorhabditis elegans</italic> aryl hydrocarbon receptor, AHR-1, regulates neuronal development</article-title>
<source/>Dev Biol
          <year>2004</year>
<volume>270</volume>
<fpage>64</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2004.02.004</pub-id>
<pub-id pub-id-type="pmid">15136141</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Strahle</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Cossins</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental defects in zebrafish (<italic>Danio rerio</italic>) at environmentally relevant dioxin (TCDD) concentrations</article-title>
<source/>Toxicol Sci
          <year>2003</year>
<volume>76</volume>
<fpage>392</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfg241</pub-id>
<pub-id pub-id-type="pmid">14600291</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gohlke</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Stockton</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Sieber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Portier</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>AhR-mediated gene expression in the developing mouse telencephalon</article-title>
<source/>Reprod Toxicol
          <year>2009</year>
<volume>28</volume>
<fpage>321</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1016/j.reprotox.2009.05.067</pub-id>
<pub-id pub-id-type="pmid">19465110</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gasiewicz</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Opanashuk</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity</article-title>
<source/>Toxicol Sci
          <year>2005</year>
<volume>83</volume>
<fpage>340</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfi031</pub-id>
<pub-id pub-id-type="pmid">15537747</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tohyama</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>AhR signaling activation disrupts migration and dendritic growth of olfactory interneurons in the developing mouse</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>26386</fpage>
<pub-id pub-id-type="doi">10.1038/srep26386</pub-id>
<pub-id pub-id-type="pmid">27197834</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<mixed-citation publication-type="other">Hsu P, Lee PY, Lee YH (2014) The role of Aryl Hydrocarbon Receptor in the excitatory synaptic protein expression in cortical neurons and brain inflammation.9th FENS Forum of Neuroscience, Milan, Italy.</mixed-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Latchney</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Hein</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>O’Banion</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>DiCicco-Bloom</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Opanashuk</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Deletion or activation of the aryl hydrocarbon receptor alters adult hippocampal neurogenesis and contextual fear memory</article-title>
<source/>J Neurochem
          <year>2013</year>
<volume>125</volume>
<fpage>430</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.12130</pub-id>
<pub-id pub-id-type="pmid">23240617</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Powell-Coffman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The <italic>Caenorhabditis elegans</italic> AHR-1 transcription complex controls expression of soluble guanylate cyclase genes in the URX neurons and regulates aggregation behavior</article-title>
<source/>Dev Biol
          <year>2006</year>
<volume>298</volume>
<fpage>606</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2006.07.017</pub-id>
<pub-id pub-id-type="pmid">16919260</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Microbiome disturbances and autism spectrum disorders</article-title>
<source/>Drug Metab Dispos
          <year>2015</year>
<volume>43</volume>
<fpage>1557</fpage>
<lpage>1571</lpage>
<pub-id pub-id-type="doi">10.1124/dmd.115.063826</pub-id>
<pub-id pub-id-type="pmid">25852213</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krajmalnik-Brown</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lozupone</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease</article-title>
<source/>Microb Ecol Health Dis
          <year>2015</year>
<volume>26</volume>
<fpage>26914</fpage>
<pub-id pub-id-type="pmid">25769266</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Hsien</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>McCue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Codelli</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Reisman</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Petrosino</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<fpage>1451</fpage>
<lpage>1463</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id>
<pub-id pub-id-type="pmid">24315484</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bull</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shattock</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Whiteley</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Groundwater</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Lough</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders</article-title>
<source/>Med Sci Monit
          <year>2003</year>
<volume>9</volume>
<fpage>CR422</fpage>
<lpage>CR425</lpage>
<pub-id pub-id-type="pmid">14523330</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tran</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Ozawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishijo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>TQ</given-names>
</name>
<name>
<surname>Hoang</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Nakai</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impacts of perinatal dioxin exposure on motor coordination and higher cognitive development in Vietnamese preschool children: a five-year follow-up</article-title>
<source/>PLoS One
          <year>2016</year>
<volume>11</volume>
<fpage>e0147655</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0147655</pub-id>
<pub-id pub-id-type="pmid">26824471</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pocivavsek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Elmer</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Schwarcz</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood</article-title>
<source/>Eur J Neurosci
          <year>2012</year>
<volume>35</volume>
<fpage>1605</fpage>
<lpage>1612</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.08064.x</pub-id>
<pub-id pub-id-type="pmid">22515201</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>FC</given-names>
</name>
</person-group>
<article-title>Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan</article-title>
<source/>Eur J Epidemiol
          <year>2014</year>
<volume>29</volume>
<fpage>57</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1007/s10654-014-9878-3</pub-id>
<pub-id pub-id-type="pmid">24442494</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Irritable bowel syndrome is associated with an increased risk of dementia: a nationwide population-based study</article-title>
<source/>PLoS One
          <year>2016</year>
<volume>11</volume>
<fpage>e0144589</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0144589</pub-id>
<pub-id pub-id-type="pmid">26731277</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McPherson</surname>
<given-names>ZE</given-names>
</name>
<name>
<surname>Talley</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McElduff</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Attia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Agar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coroneo</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Petterson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel predictive association between irritable bowel syndrome and glaucomatous optic neuropathy</article-title>
<source/>Gastroenterology
          <year>2015</year>
<volume>148</volume>
<fpage>S404</fpage>
<pub-id pub-id-type="doi">10.1016/S0016-5085(15)31360-3</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berstad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Raa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Valeur</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Tryptophan: ‘essential’ for the pathogenesis of irritable bowel syndrome?</article-title>
<source/>Scand J Gastroenterol
          <year>2014</year>
<volume>49</volume>
<fpage>1493</fpage>
<lpage>1498</lpage>
<pub-id pub-id-type="doi">10.3109/00365521.2014.936034</pub-id>
<pub-id pub-id-type="pmid">25000845</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>de Vos</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Bohl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Del Tredici</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology</article-title>
<source/>Neurosci Lett
          <year>2006</year>
<volume>396</volume>
<fpage>67</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2005.11.012</pub-id>
<pub-id pub-id-type="pmid">16330147</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Carvey</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bakay</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Kordower</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson’s disease</article-title>
<source/>Mov Disord
          <year>2014</year>
<volume>29</volume>
<fpage>999</fpage>
<lpage>1009</lpage>
<pub-id pub-id-type="doi">10.1002/mds.25736</pub-id>
<pub-id pub-id-type="pmid">24898698</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheperjans</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aho</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Koskinen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Paulin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pekkonen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Haapaniemi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kaakkola</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eerola-Rautio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pohja</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota are related to Parkinson’s disease and clinical phenotype</article-title>
<source/>Mov Disord
          <year>2015</year>
<volume>30</volume>
<fpage>350</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1002/mds.26069</pub-id>
<pub-id pub-id-type="pmid">25476529</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<mixed-citation publication-type="other">Harach T, Marungruang N, Dutilleul N, Cheatham V, McCoy KD, Neher JJ, Jucker M, Fak F, Lasser T, Bolmont T (2015) Reduction of Alzheimer’s disease beta-amyloid pathology in the absence of gut microbiotaarXiv:150902273 [q-bioMN].</mixed-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacob</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hartz</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Potin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Coumoul</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yousif</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scherrmann</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Decleves</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels</article-title>
<source/>Fluids Barriers CNS
          <year>2011</year>
<volume>8</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.1186/2045-8118-8-23</pub-id>
<pub-id pub-id-type="pmid">21867498</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filbrandt</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zlokovic</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Opanashuk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gasiewicz</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes</article-title>
<source/>Neurotoxicology
          <year>2004</year>
<volume>25</volume>
<fpage>605</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2003.08.007</pub-id>
<pub-id pub-id-type="pmid">15183014</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montagne</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Halliday</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Sagare</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Toga</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Amezcua</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blood-brain barrier breakdown in the aging human hippocampus</article-title>
<source/>Neuron
          <year>2015</year>
<volume>85</volume>
<fpage>296</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.032</pub-id>
<pub-id pub-id-type="pmid">25611508</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frohlich</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Farzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mayerhofer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reichmann</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jacan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zinser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bordag</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Magnes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Frohlich</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication</article-title>
<source/>Brain Behav Immun
          <year>2016</year>
<volume>56</volume>
<fpage>140</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2016.02.020</pub-id>
<pub-id pub-id-type="pmid">26923630</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dauchy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dutheil</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Chassoux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Daumas-Duport</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Couraud</surname>
<given-names>PO</given-names>
</name>
<name>
<surname>Scherrmann</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>De Waziers</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Decleves</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier</article-title>
<source/>J Neurochem
          <year>2008</year>
<volume>107</volume>
<fpage>1518</fpage>
<lpage>1528</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05720.x</pub-id>
<pub-id pub-id-type="pmid">19094056</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>Activating PKC-beta1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS</article-title>
<source/>J Cereb Blood Flow Metab
          <year>2011</year>
<volume>31</volume>
<fpage>1371</fpage>
<lpage>1375</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2011.44</pub-id>
<pub-id pub-id-type="pmid">21487415</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor-mediated upregulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier</article-title>
<source/>FASEB J
          <year>2011</year>
<volume>25</volume>
<fpage>644</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1096/fj.10-169227</pub-id>
<pub-id pub-id-type="pmid">21048045</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Juan</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Mediating effects of aryl-hydrocarbon receptor and RhoA in altering brain vascular integrity: the therapeutic potential of statins</article-title>
<source/>Am J Pathol
          <year>2012</year>
<volume>181</volume>
<fpage>211</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2012.03.032</pub-id>
<pub-id pub-id-type="pmid">22720799</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takei</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mitoma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hashimoto-Hachiya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takahara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nakahara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Furue</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Galactomyces fermentation filtrate prevents T helper 2-mediated reduction of filaggrin in an aryl hydrocarbon receptor-dependent manner</article-title>
<source/>Clin Exp Dermatol
          <year>2015</year>
<volume>40</volume>
<fpage>786</fpage>
<lpage>793</lpage>
<pub-id pub-id-type="doi">10.1111/ced.12635</pub-id>
<pub-id pub-id-type="pmid">25786502</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrysik</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Prochazkova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kabatkova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Umannova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Simeckova</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kohoutek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kozubik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Machala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vondracek</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor-mediated disruption of contact inhibition is associated with connexin43 downregulation and inhibition of gap junctional intercellular communication</article-title>
<source/>Arch Toxicol
          <year>2013</year>
<volume>87</volume>
<fpage>491</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1007/s00204-012-0963-7</pub-id>
<pub-id pub-id-type="pmid">23085979</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabatkova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Svobodova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pencikova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mohatad</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Smerdova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kozubik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Machala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vondracek</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Interactive effects of inflammatory cytokine and abundant low-molecular-weight PAHs on inhibition of gap junctional intercellular communication, disruption of cell proliferation control, and the AhR-dependent transcription</article-title>
<source/>Toxicol Lett
          <year>2014</year>
<volume>232</volume>
<fpage>113</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2014.09.023</pub-id>
<pub-id pub-id-type="pmid">25268939</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ezan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Andre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cisternino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saubamea</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Boulay</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Doutremer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Quenech’du</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giaume</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cohen-Salmon</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Deletion of astroglial connexins weakens the blood-brain barrier</article-title>
<source/>J Cereb Blood Flow Metab
          <year>2012</year>
<volume>32</volume>
<fpage>1457</fpage>
<lpage>1467</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2012.45</pub-id>
<pub-id pub-id-type="pmid">22472609</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boulay</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Mazeraud</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cisternino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saubamea</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mailly</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jourdren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Blugeon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mignon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Smirnova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cavallo</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immune quiescence of the brain is set by astroglial connexin 43</article-title>
<source/>J Neurosci
          <year>2015</year>
<volume>35</volume>
<fpage>4427</fpage>
<lpage>4439</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2575-14.2015</pub-id>
<pub-id pub-id-type="pmid">25762685</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esser</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rannug</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The aryl hydrocarbon receptor in immunity</article-title>
<source/>Trends Immunol
          <year>2009</year>
<volume>30</volume>
<fpage>447</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2009.06.005</pub-id>
<pub-id pub-id-type="pmid">19699679</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation</article-title>
<source/>Front Cell Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>476</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00476</pub-id>
<pub-id pub-id-type="pmid">26733805</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reus</surname>
<given-names>GZ</given-names>
</name>
<name>
<surname>Fries</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Stertz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Badawy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Passos</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Barichello</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kapczinski</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Quevedo</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders</article-title>
<source/>Neuroscience
          <year>2015</year>
<volume>300</volume>
<fpage>141</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.05.018</pub-id>
<pub-id pub-id-type="pmid">25981208</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Microglial priming in neurodegenerative disease</article-title>
<source/>Nat Rev Neurol
          <year>2014</year>
<volume>10</volume>
<fpage>217</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2014.38</pub-id>
<pub-id pub-id-type="pmid">24638131</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erny</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hrabe de Angelis</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Jaitin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wieghofer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Staszewski</surname>
<given-names>O</given-names>
</name>
<name>
<surname>David</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Keren-Shaul</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mahlakoiv</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jakobshagen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Buch</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<fpage>965</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4030</pub-id>
<pub-id pub-id-type="pmid">26030851</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madore</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fanek</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kinner</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Yeliseyev</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bry</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Butovsky</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Dysregulation of the homeostatic microglia signature in germ-free mice</article-title>
<source/>J Neuroimmunol
          <year>2014</year>
<volume>275</volume>
<fpage>161</fpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2014.08.433</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kuan</surname>
<given-names>CY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aryl hydrocarbon receptor mediates both pro-inflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia</article-title>
<source/>Glia
          <year>2015</year>
<volume>63</volume>
<fpage>1138</fpage>
<lpage>1154</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22805</pub-id>
<pub-id pub-id-type="pmid">25690886</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Fariss</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Rachel</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Cogliati</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion of aryl hydrocarbon receptor AHR in mice leads to subretinal accumulation of microglia and RPE atrophy</article-title>
<source/>Invest Ophthalmol Vis Sci
          <year>2014</year>
<volume>55</volume>
<fpage>6031</fpage>
<lpage>6040</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.14-15091</pub-id>
<pub-id pub-id-type="pmid">25159211</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothhammer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mascanfroni</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Bunse</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kenison</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Blain</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor</article-title>
<source/>Nat Med
          <year>2016</year>
<pub-id pub-id-type="pmid">27158906</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khakh</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Sofroniew</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Diversity of astrocyte functions and phenotypes in neural circuits</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<fpage>942</fpage>
<lpage>952</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4043</pub-id>
<pub-id pub-id-type="pmid">26108722</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofroniew</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Astrocyte barriers to neurotoxic inflammation</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<fpage>249</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3898</pub-id>
<pub-id pub-id-type="pmid">25891508</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EH</given-names>
</name>
</person-group>
<article-title>Indirubin-3′-oxime inhibits inflammatory activation of rat brain microglia</article-title>
<source/>Neurosci Lett
          <year>2011</year>
<volume>487</volume>
<fpage>139</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2010.10.009</pub-id>
<pub-id pub-id-type="pmid">20946938</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<mixed-citation publication-type="other">Winek K, Engel O, Koduah P, Heimesaat MM, Fischer A, Bereswill S, Dames C, Kershaw O, Gruber AD, Curato C et al. (2016) Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke. Stroke 47: 1354–1363</mixed-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benakis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brea</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Caballero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Faraco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sita</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Racchumi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pamer</surname>
<given-names>EG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Commensal microbiota affects ischemic stroke outcome by regulating intestinal gamma delta T cells</article-title>
<source/>Nat Med
          <year>2016</year>
<volume>22</volume>
<fpage>516</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4068</pub-id>
<pub-id pub-id-type="pmid">27019327</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Llovera</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sadler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Garzetti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stecher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dichgans</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liesz</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Microbiota dysbiosis controls the neuroinflammatory response after stroke</article-title>
<source/>J Neurosci
          <year>2016</year>
<volume>36</volume>
<fpage>7428</fpage>
<lpage>7440</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1114-16.2016</pub-id>
<pub-id pub-id-type="pmid">27413153</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cua</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Veldhoen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Interleukin-17-producing gamma delta T cells selectively expand in response to pathogen products and environmental signals</article-title>
<source/>Immunity
          <year>2009</year>
<volume>31</volume>
<fpage>321</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2009.06.020</pub-id>
<pub-id pub-id-type="pmid">19682928</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ormstad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Verkerk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Amthor</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Sandvik</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Activation of the kynurenine pathway in the acute phase of stroke and its role in fatigue and depression following stroke</article-title>
<source/>J Mol Neurosci
          <year>2014</year>
<volume>54</volume>
<fpage>181</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1007/s12031-014-0272-0</pub-id>
<pub-id pub-id-type="pmid">24664436</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Pi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke</article-title>
<source/>J Clin Neurosci
          <year>2014</year>
<volume>21</volume>
<fpage>482</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1016/j.jocn.2013.08.020</pub-id>
<pub-id pub-id-type="pmid">24412293</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darlington</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Forrest</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Stoy</surname>
<given-names>N</given-names>
</name>
<name>
<surname>George</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>TW</given-names>
</name>
</person-group>
<article-title>Altered kynurenine metabolism correlates with infarct volume in stroke</article-title>
<source/>Eur J Neurosci
          <year>2007</year>
<volume>26</volume>
<fpage>2211</fpage>
<lpage>2221</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05838.x</pub-id>
<pub-id pub-id-type="pmid">17892481</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuartero</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Ballesteros</surname>
<given-names>I</given-names>
</name>
<name>
<surname>de la Parra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Harkin</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Abautret-Daly</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sherwin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fernandez-Salguero</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Corbi</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Lizasoain</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Moro</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke</article-title>
<source/>Circulation
          <year>2014</year>
<volume>130</volume>
<fpage>2040</fpage>
<lpage>2051</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.011394</pub-id>
<pub-id pub-id-type="pmid">25359166</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>